Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Current Assets (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Current Assets data on record, last reported at $118.5 million in Q3 2025.

  • For Q3 2025, Current Assets rose 37.35% year-over-year to $118.5 million; the TTM value through Sep 2025 reached $118.5 million, up 37.35%, while the annual FY2024 figure was $90.4 million, 22.77% down from the prior year.
  • Current Assets reached $118.5 million in Q3 2025 per FBIO's latest filing, up from $110.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $346.5 million in Q4 2021 and bottomed at $86.3 million in Q3 2024.
  • Average Current Assets over 5 years is $205.1 million, with a median of $179.0 million recorded in 2022.
  • Peak YoY movement for Current Assets: skyrocketed 100.25% in 2021, then plummeted 57.32% in 2023.
  • A 5-year view of Current Assets shows it stood at $346.5 million in 2021, then crashed by 33.49% to $230.4 million in 2022, then tumbled by 49.22% to $117.0 million in 2023, then decreased by 22.77% to $90.4 million in 2024, then soared by 31.13% to $118.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $118.5 million in Q3 2025, $110.4 million in Q2 2025, and $126.9 million in Q1 2025.